Seventy two people with clinically significant agitation in the context of severe dementia, residing in NHS care facilities, were randomized to aromatherapy with Melissa (lemon balm) essential oil or placebo (sunflower oil). Changes in clinically significant agitation (Cohen-Mansfield Agitation Inventory -CMAI) and quality of life indices (% social withdrawal and % constructive activities measured with Dementia Care Mapping) were compared between the 2 groups over a 4 week period of treatment.
Seventy-one patients completed the trial. No significant side effects were observed. Sixty percent of the active treatment group and 14% of the placebo treated group experienced a 30% reduction of CMAI score, with an overall improvement in agitation of 35% in patients receiving melissa essential oil and 11% in those treated with placebo (Mann-Whitney U test -MWU - Z=4.1, p<0.0001). Quality of life indices also improved significantly more in people receiving essential balm oil (% social withdrawal MWU Z=2.6 p=0.005, %constructive activities MWU Z 3.5 p=0.001).
Aromatherapy with essential balm oil is a safe treatment which appears to be efficacious for the treatment of clinically significant agitation in people with severe dementia, with additional benefits for key quality of life parameters.
Aromatherapy Agitation Dementia Quality of life
To read the text of the complete research click download